Viewing Study NCT03102320

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:12 AM

Ignite Modification Date: 2025-12-26 @ 3:10 AM

Study NCT ID: NCT03102320

Status: COMPLETED

Last Update Posted: 2022-06-30

First Post: 2017-03-30

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

Sponsor: Bayer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module